Cargando…

The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer

Androgen deprivation therapies aimed to target prostate cancer (PrCa) are only partially successful given the occurrence of neuroendocrine PrCa (NEPrCa), a highly aggressive and highly metastatic form of PrCa, for which there is no effective therapeutic approach. Our group has demonstrated that whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Quaglia, Fabio, Krishn, Shiv Ram, Sossey-Alaoui, Khalid, Rana, Priyanka Shailendra, Pluskota, Elzbieta, Park, Pyung Hun, Shields, Christopher D., Lin, Stephen, McCue, Peter, Kossenkov, Andrew V., Wang, Yanqing, Goodrich, David W., Ku, Sheng-Yu, Beltran, Himisha, Kelly, William K., Corey, Eva, Klose, Maja, Bandtlow, Christine, Liu, Qin, Altieri, Dario C., Plow, Edward F., Languino, Lucia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640716/
https://www.ncbi.nlm.nih.gov/pubmed/36344556
http://dx.doi.org/10.1038/s41598-022-21711-5